Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin with Ahmed Valve in Refractory Glaucoma
NCT01128699Phase 3Unknown
- Sponsor
- Vanak Eye Surgery Center
- Start
- May 2010
- Primary completion
- May 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in refractory glaucoma, sponsored by Vanak Eye Surgery Center. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
refractory glaucoma
Beyond the preview
Go deeper on NCT01128699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128699.